|
|
|
|
|
|
|
Infinity Pharmaceuti (INFI)
|
|
2.24 0.04 (1.82%)
|
04-20 16:00
|
|
Open:
|
2.24
|
Pre. Close:
|
2.2
|
|
High:
|
2.25
|
Low:
|
2.16
|
|
Volume:
|
377,923
|
Market Cap:
|
116M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.253 - 2.262
|
2.262 - 2.271
|
|
Low:
|
2.138 - 2.148
|
2.148 - 2.157
|
|
Close:
|
2.224 - 2.24
|
2.24 - 2.255
|
|
|
|
Technical analysis (as of: 2018-04-20 4:30:51 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 2.75  One year: 3.12
|
|
Support:
|
Support1: 1.85 Support2: 1.54
|
|
Resistance:
|
Resistance1:
2.36 Resistance2: 2.67
|
|
Pivot:
|
2.09 
|
|
Moving Averages:
|
MA(5): 2.21 MA(20): 2.11
MA(100): 2.09 MA(250): 1.83
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9): -0.02
|
|
%K %D:
|
%K(14,3): 73.47 %D(3): 72.79
|
|
RSI:
|
RSI(14): 53.74
|
|
52-Week:
|
High: 3.75
Low: 0.93 Change(%): 14.3
|
|
Average Vol(K):
|
3-Month: 76430
10-Days 76850
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.INFI has closed below upper band by 20.8%. Bollinger Bands are 14.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-12T18:20:00-04:00
Daily Insider Ratings Round Up 4/11/18: INFI, ETM, LGCY, CCUR, OPK, DEX
2018-03-27T14:39:25-04:00
Infinity Pharmaceuticals (INFI) Presents At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference - Slideshow
2018-03-26T08:32:00-04:00
Infinity to Present at Two Upcoming Conferences
2018-03-21T11:36:00-04:00
Infinity To Present At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference
2018-03-15T21:28:07-04:00
Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q4 2017 Results - Earnings Call Transcript
2018-03-15T16:20:15-04:00
Infinity Pharmaceuticals beats by $0.11
2018-03-15T16:05:00-04:00
Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results
2018-03-11T15:56:09-04:00
Week 11 Breakout Forecast: Short-Term Picks To Give You An Edge
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
